Ocugen Signs Licensing Term Sheet for OCU400 with Roots Pharmaceutical
Ocugen has signed a binding term sheet to negotiate a licensing agreement granting exclusive rights for its gene therapy, OCU400, in the Middle East and North Africa. The deal involves Roots Pharmaceutical and Al-Dhow International Holding.
Topics: biotech gene therapy licensing agreement